« Back to the previous page

Also available in:

Buyer for a small molecules CMO in Europe

Company to buy

  • Size: Med-size
  • Revenue: 5-50 million EUR
  • Location of the target company: Europe 
  • Reason for acquisition: The company wants a small molecules CMO to expand the company’s operations in Europe
  • #CFIE PHB140

Overview of this buyer for a small molecules CMO in Europe

This buyer is a large CDMO company engaged in discovering and developing small molecule therapies. The company is interested in expanding its operations through the acquisition of a suitable CMO company in Europe.

Profile (strategy) of this buyer for a small molecules CMO in Europe

The buyer is a large company with more than 10 years of history focused on drug discovery. The company provides to its clients a broad range of services, since a target validation to a selection of clinical candidate. The company offers a full-integrated drug discovery program including medicinal and synthetic chemistry, computer-aided drug design, structural biology, in vitro and in vivo pharmacology, ADME/DMPK, toxicology and analytical testing. Besides a drug discovery, the company also offer services in different areas such as research and development and regulatory studies. The company have been developing new molecules and new solutions to the biggest pharmaceutical companies around the world over a decade.   

The company has its HQ in Europe and offices across the world, with two plants in Europe. The company has more than 12,000 sqm facilities securing laboratory space for further growth. All the research sites are equipped with state-of-the-art devices and are conducted under Good Manufacturing Practice (GMP) and Good Laboratory Practice (GLP). 

The company has a presence worldwide and more than 500 employees and 100+ million EUR in revenue.

Contact us to get details about this buyer for a small molecules CMO in Europe

Activities and products of the target 

The buyer is looking for a CMO company in Europe, especially in Central and Eastern Europe, but don’t discard any other option. An interesting company to this buyer would be a med sized CMO company focused on health care and biotechnology with GMP certification. The company should have a good EBITDA margin and be profitable.

Highlights of this Buyer for a small molecules CMO in Europe

  • More than 10 years of history
  • Stock listed company
  • Revenue of 100+ million EUR
  • Acquisition background
  • Worldwide presence

Information about this buyer for a small molecules CMO in Europe

Feel free to contact us for more information regarding this Buyer for a small molecules CMO in Europe or if you know possible interested or suitable parties. For more buyers for a small molecules CMO in Europe, please visit the section pharmaceutical companies wanted. For pharmaceutical firms for sale visit the section pharmaceutical companies for sale



Note: CFIE only works with formal companies. We do get a lot of requests and it is difficult to follow up on all inquiries from visitors to our website. For each company we assess the likelihood of a future transaction. We only get back to you if we see a realistic opportunity to do a future acquisition or business sale. In order to increase your chances of receiving a reply as an individual please explain as much as possible about your personal background strategy and fit with the target. There is also a possibility that your details will be kept on file and we will get back to you once there is an opportunity to do a transaction. CFIE can’t guarantee you will receive an answer to your request.